Status:
ENROLLING_BY_INVITATION
The Effect of Thalamic Stimulation on Sleep Oscillations
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Sleep
Neuromodulation
Eligibility:
All Genders
5-85 years
Phase:
NA
Brief Summary
The thalamus plays a key role in supporting sleep and is also a target of therapeutic stimulation. This project investigates when, where, and how electrical stimulation delivered to the thalamus in hu...
Detailed Description
The thalamus plays a key role in supporting sleep. The thalamus is also increasingly used as a stimulation therapeutic target, but the effect of thalamic stimulation on sleep has not been investigated...
Eligibility Criteria
Inclusion
- Patients getting intracranial recordings for clinical purposes who, as part of that plan, will receive thalamic electrodes.
Exclusion
- previous extensive resection or large atrophy
Key Trial Info
Start Date :
January 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2029
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07217080
Start Date
January 6 2025
End Date
November 30 2029
Last Update
October 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02114-2696
2
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114-2696